| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00018 | 1 |